{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:13:52Z","timestamp":1787318032231,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1400-2-101-54577"],"award-info":[{"award-number":["1400-2-101-54577"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10787-024-01536-6","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T12:45:45Z","timestamp":1724330745000},"page":"3181-3193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-0120","authenticated-orcid":false,"given":"Mehrnoosh","family":"Pashaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-2697","authenticated-orcid":false,"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4762-6943","authenticated-orcid":false,"given":"Hoda","family":"Kavosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-2179","authenticated-orcid":false,"given":"Elham","family":"Madreseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-5143","authenticated-orcid":false,"given":"Samaneh","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-8831","authenticated-orcid":false,"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2519","authenticated-orcid":false,"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"1536_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, VARGA J (2015) Systemic sclerosis. Nat Rev Dis Prim 1:1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2015.2","journal-title":"Nat Rev Dis Prim"},{"key":"1536_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7555\/JBR.31.20170034","volume":"32","author":"NB Ayers","year":"2018","unstructured":"Ayers NB, Sun CM, Chen SY (2018) Transforming growth factor-\u03b2 signaling in systemic sclerosis. J Biomed Res 32:3\u201312. https:\/\/doi.org\/10.7555\/JBR.31.20170034","journal-title":"J Biomed Res"},{"key":"1536_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/721608","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Anderson ME, Moots RJ (2011) The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol. https:\/\/doi.org\/10.1155\/2011\/721608","journal-title":"Int J Rheumatol"},{"key":"1536_CR4","first-page":"94","volume":"31","author":"B Dziankowska-Bartkowiak","year":"2006","unstructured":"Dziankowska-Bartkowiak B, Zebrowska A, Joss-Wichman E, Kobos J, Waszczykowska E (2006) Expression of metalloproteinases and their inhibitors in skin lesions of systemic sclerosis {SSc) patients. Central Eur J Immunol 31:94","journal-title":"Central Eur J Immunol"},{"key":"1536_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","volume":"809","author":"C Egger","year":"2017","unstructured":"Egger C, Cannet C, G\u00e9rard C, Suply T, Ksiazek I, Jarman E, Beckmann N (2017) Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol 809:64\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.022","journal-title":"Eur J Pharmacol"},{"key":"1536_CR6","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"M-H Fan","year":"2016","unstructured":"Fan M-H, Zhu Q, Li H-H, Ra H-J, Majumdar S, Gulick DL, Jerome JA, Madsen DH, Christofidou-Solomidou M, Speicher DW (2016) Fibroblast activation protein (FAP) accelerates collagen degradation and clearance from lungs in mice. J Biol Chem 291:8070\u20138089. https:\/\/doi.org\/10.1074\/jbc.M115.701433","journal-title":"J Biol Chem"},{"key":"1536_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM (2020) The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev 39:783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3","journal-title":"Cancer Metastasis Rev"},{"key":"1536_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/onc.2012.171","volume":"32","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C (2013) TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 32:1549\u20131559","journal-title":"Oncogene"},{"key":"1536_CR9","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989\u20132003. https:\/\/doi.org\/10.1056\/NEJMra0806188","journal-title":"N Engl J Med"},{"key":"1536_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1185\/030079905X30680","volume":"21","author":"G Giannelli","year":"2005","unstructured":"Giannelli G, Iannone F, Marinosci F, Lapadula G, Antonaci S (2005) The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension. Curr Med Res Opin 21:327\u2013332. https:\/\/doi.org\/10.1185\/030079905X30680","journal-title":"Curr Med Res Opin"},{"key":"1536_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4230","volume":"15","author":"AJ Gilbane","year":"2013","unstructured":"Gilbane AJ, Denton CP, Holmes AM (2013) Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther 15:1\u20139. https:\/\/doi.org\/10.1186\/ar4230","journal-title":"Arthritis Res Ther"},{"key":"1536_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/156652412803833607","volume":"12","author":"M Jacob","year":"2012","unstructured":"Jacob M, Chang L, Pure E (2012) Fibroblast activation protein in remodeling tissues. Curr Mol Med 12:1220\u20131243. https:\/\/doi.org\/10.2174\/156652412803833607","journal-title":"Curr Mol Med"},{"key":"1536_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","volume":"24","author":"DC Johnson","year":"2018","unstructured":"Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A (2018) DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med 24:1151\u20131156. https:\/\/doi.org\/10.1038\/s41591-018-0082-y","journal-title":"Nat Med"},{"key":"1536_CR14","doi-asserted-by":"publisher","first-page":"17300","DOI":"10.1038\/s41598-020-74179-6","volume":"10","author":"P Juhl","year":"2020","unstructured":"Juhl P, Bondesen S, Hawkins CL, Karsdal MA, Bay-Jensen A-C, Davies MJ, Siebuhr AS (2020) Dermal fibroblasts have different extracellular matrix profiles induced by TGF-\u03b2, PDGF and IL-6 in a model for skin fibrosis. Sci Rep 10:17300. https:\/\/doi.org\/10.1038\/s41598-020-74179-6","journal-title":"Sci Rep"},{"key":"1536_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R (2014) Transforming growth factor \u03b2\u2014at the centre of systemic sclerosis. Nat Rev Rheumatol 10:706\u2013719. https:\/\/doi.org\/10.1038\/nrrheum.2014.137","journal-title":"Nat Rev Rheumatol"},{"key":"1536_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"H-O Lee","year":"2011","unstructured":"Lee H-O, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD (2011) FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer 11:1\u201313. https:\/\/doi.org\/10.1186\/1471-2407-11-245","journal-title":"BMC Cancer"},{"key":"1536_CR17","doi-asserted-by":"publisher","first-page":"727451","DOI":"10.3389\/fphys.2021.727451","volume":"12","author":"E Leong","year":"2021","unstructured":"Leong E, Bezuhly M, Marshall JS (2021) Distinct metalloproteinase expression and functions in systemic sclerosis and fibrosis: what we know and the potential for intervention. Front Physiol 12:727451. https:\/\/doi.org\/10.3389\/fphys.2021.727451","journal-title":"Front Physiol"},{"key":"1536_CR18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.510290631","volume":"29","author":"MT Levy","year":"1999","unstructured":"Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, M\u00fcller E, Rettig WJ, Gorrell MD (1999) Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 29:1768\u20131778","journal-title":"Hepatology"},{"key":"1536_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","volume":"22","author":"M Levy","year":"2002","unstructured":"Levy M, McCaughan G, Marinos G, Gorrell M (2002) Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver 22:93\u2013101. https:\/\/doi.org\/10.1034\/j.1600-0676.2002.01503.x","journal-title":"Liver"},{"key":"1536_CR20","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.7150\/ijbs.75876","volume":"18","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao J, Yin Y, Li K, Zhang C, Zheng Y (2022) The Role of IL-6 in fibrotic diseases: molecular and cellular mechanisms. Int J Biol Sci 18:5405. https:\/\/doi.org\/10.7150\/ijbs.75876","journal-title":"Int J Biol Sci"},{"key":"1536_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"1536_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/embor.2009.276","volume":"11","author":"C Margadant","year":"2010","unstructured":"Margadant C, Sonnenberg A (2010) Integrin\u2013TGF-\u03b2 crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97\u2013105. https:\/\/doi.org\/10.1038\/embor.2009.276","journal-title":"EMBO Rep"},{"key":"1536_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.0022-202X.2005.23701.x","volume":"124","author":"Y Mimura","year":"2005","unstructured":"Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K (2005) Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. J Investig Dermatol 124:886\u2013892. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23701.x","journal-title":"J Investig Dermatol"},{"key":"1536_CR24","first-page":"338","volume":"20","author":"MJ Mousavi","year":"2021","unstructured":"Mousavi MJ, Farhadi E, Vodjgani M, Karami J, Tahmasebi MN, Vaziri AS, Asgari M, Rezaei N, Mostafaei S, Jamshidi A, Mahmoudi M (2021) Role of fibroblast activation protein alpha in fibroblast-like synoviocytes of rheumatoid arthritis. Iran J Allergy Asthma Immunol 20:338\u2013349","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1536_CR25","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","volume":"6","author":"K Narra","year":"2007","unstructured":"Narra K, Mullins SR, Lee H-O, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM (2007) Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol Therapy 6:1691\u20131699. https:\/\/doi.org\/10.4161\/cbt.6.11.4874","journal-title":"Cancer Biol Therapy"},{"key":"1536_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/07357900600894732","volume":"24","author":"J Nemunaitis","year":"2006","unstructured":"Nemunaitis J, Vukelja SJ, Richards D, Cunningham C, Senzer N, Nugent J, Duncan H, Jones B, Haltom E, Uprichard MJ (2006) Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy. Cancer Invest 24:553\u2013561. https:\/\/doi.org\/10.1080\/07357900600894732","journal-title":"Cancer Invest"},{"key":"1536_CR27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1021\/jm100972f","volume":"54","author":"SE Poplawski","year":"2011","unstructured":"Poplawski SE, Lai JH, Sanford DG, Sudmeier JL, Wengen W, Bachovchin WW (2011) Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases. J Med Chem 54:2022\u20132028. https:\/\/doi.org\/10.1021\/jm100972f","journal-title":"J Med Chem"},{"key":"1536_CR28","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1074\/jbc.M706387200","volume":"283","author":"B Poree","year":"2008","unstructured":"Poree B, Kypriotou M, Chadjichristos C, Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann D-J, Mallein-Gerin F (2008) Interleukin-6 (IL-6) and\/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1\u00b7 Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem 283:4850\u20134865. https:\/\/doi.org\/10.1074\/jbc.M706387200","journal-title":"J Biol Chem"},{"key":"1536_CR29","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI77958","volume":"125","author":"LM Rice","year":"2015","unstructured":"Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML (2015) Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J Clin Investig 125:2795\u20132807. https:\/\/doi.org\/10.1172\/JCI77958","journal-title":"J Clin Investig"},{"key":"1536_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato S, Hasegawa M, Takehara K (2001) Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 27:140\u2013146. https:\/\/doi.org\/10.1016\/s0923-1811(01)00128-1","journal-title":"J Dermatol Sci"},{"key":"1536_CR31","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","volume":"9","author":"A van Caam","year":"2018","unstructured":"van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P (2018) Unraveling SSc pathophysiology; the myofibroblast. Front Immunol 9:2452. https:\/\/doi.org\/10.3389\/fimmu.2018.02452","journal-title":"Front Immunol"},{"key":"1536_CR32","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger JR, Carreira PE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheumatism 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheumatism"},{"key":"1536_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Investig 117:557\u2013567. https:\/\/doi.org\/10.1172\/JCI31139","journal-title":"J Clin Investig"},{"key":"1536_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti MP, Brinckerhoff CE (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res Ther 4:1\u20138. https:\/\/doi.org\/10.1186\/ar401","journal-title":"Arthritis Res Ther"},{"key":"1536_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13075-022-02779-w","volume":"24","author":"DC Zanin-Silva","year":"2022","unstructured":"Zanin-Silva DC, Santana-Gon\u00e7alves M, Kawashima-Vasconcelos MY, Lima-J\u00fanior JR, Dias JBE, Moraes DA, Covas DT, Malmegrim KCR, Ramalho L, Oliveira MC (2022) Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Res Ther 24:95. https:\/\/doi.org\/10.1186\/s13075-022-02779-w","journal-title":"Arthritis Res Ther"},{"key":"1536_CR36","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1038\/srep19276","volume":"6","author":"X-K Zhao","year":"2016","unstructured":"Zhao X-K, Cheng Y, Cheng ML, Lei Yu, Mao Mu, Li H, Liu Y, Zhang B, Yao Y, Guo H, Wang R, Zhang Q (2016) Focal adhesion kinase regulates fibroblast migration via integrin beta-1 and plays a central role in fibrosis. Sci Rep 6:19276. https:\/\/doi.org\/10.1038\/srep19276","journal-title":"Sci Rep"},{"key":"1536_CR37","doi-asserted-by":"publisher","first-page":"e0191031","DOI":"10.1371\/journal.pone.0191031","volume":"13","author":"W Zhao","year":"2018","unstructured":"Zhao W, Wang X, Sun K-H, Zhou L (2018) \u03b1-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. PLoS ONE 13:e0191031. https:\/\/doi.org\/10.1371\/journal.pone.0191031","journal-title":"PLoS ONE"},{"key":"1536_CR38","doi-asserted-by":"publisher","first-page":"2104128","DOI":"10.1002\/advs.202104128","volume":"9","author":"R Zhao","year":"2022","unstructured":"Zhao R, Jin X, Li A, Bitong Xu, Shen Y, Wang W, Huang J, Zhang Y, Li X (2022) Precise diabetic wound therapy: PLS nanospheres eliminate senescent cells via DPP4 targeting and PARP1 activation. Adv Sci 9:2104128. https:\/\/doi.org\/10.1002\/advs.202104128","journal-title":"Adv Sci"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01536-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T12:12:52Z","timestamp":1726920772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01536-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01536-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or non-financial competing interests that are directly or indirectly related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Human Research Ethics Committee of the Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1400.825). All participants involved in the study provided their consent by signing an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}